Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
4.350
-0.030 (-0.68%)
Jun 24, 2025, 4:00 PM - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $156.21 million as of June 25, 2025. Its market cap has increased by 61.70% in one year.
Market Cap
156.21M
Enterprise Value
159.08M
1-Year Change
61.70%
Ranking
Category
Stock Price
4.35
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $156.21M, an increase of 153.51%. That is a compound annual growth rate of 24.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 154.56M | 38.43% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |